Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C36H71NO4 |
Molecular Weight | 581.9532 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC
InChI
InChIKey=ATGQXSBKTQANOH-UWVGARPKSA-N
InChI=1S/C36H71NO4/c1-3-5-7-9-11-13-15-17-18-19-21-23-25-27-29-31-35(40)37-33(32-38)36(41)34(39)30-28-26-24-22-20-16-14-12-10-8-6-4-2/h17-18,33-34,36,38-39,41H,3-16,19-32H2,1-2H3,(H,37,40)/b18-17-/t33-,34+,36-/m0/s1
Molecular Formula | C36H71NO4 |
Molecular Weight | 581.9532 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
CERAMIDE NP (previously CERAMIDE 3) is a naturally occurring lipid and major component of the stratum corneum (outer skin layer). Levels of CERAMIDE NP decrease with advancing age. CERAMIDE NP is widely used as a moisturizer in cosmetic products because of its hydrating function. Interactions have been found with ceramide 1, synergistically improving the skin barrier function in humans, i.e. better skin hydration and less transepidermal water loss. There are no safety concerns for cosmetic products containing less than 1% CERAMIDE NP.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:55:19 UTC 2023
by
admin
on
Sat Dec 16 01:55:19 UTC 2023
|
Record UNII |
4370DF050B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
57378373
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
PRIMARY | |||
|
SUB126769
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
PRIMARY | |||
|
4370DF050B
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
PRIMARY | |||
|
100000152987
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
PRIMARY | |||
|
4370DF050B
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
PRIMARY | |||
|
67035
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
PRIMARY | |||
|
100403-19-8
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
NO STRUCTURE GIVEN | |||
|
34354-88-6
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
MAJOR COMPONENT STRUCTURE/SEQUENCE | |||
|
1362741
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB14111
Created by
admin on Sat Dec 16 01:55:19 UTC 2023 , Edited by admin on Sat Dec 16 01:55:19 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|